Cephalosporin

I routinely see prescribers avoid prescribing cephalosporin antibiotics for patients with a penicillin allergy.

New estimates presented at ESCMID Global Congress show that antimicrobial resistance prevalence in WHO gram-negative priority pathogens may be “substantial” in countries lacking current data.

High-risk patients who had a verified penicillin allergy safely received cephalosporins, according to a letter published in The Journal of Allergy and Clinical Immunology: In Practice.

High-risk patients with a verified penicillin allergy safely received cephalosporins, according to a letter published in The Journal of Allergy and Clinical Immunology: In Practice.

Shionogi won FDA approval for Fetroja for the treatment of complicated UTIs, or cUTIs, in adults with limited or no alternative treatment options.

An FDA committee voted to recommend the approval of cefiderocol for the treatment complicated UTIs, or cUTIs, in patients with few or no alternative treatment options.

WASHINGTON — Cefiderocol, a novel siderophore cephalosporin, was noninferior to high-dose meropenem for the primary endpoint of all-cause mortality 14 days after treatment was started in patients with nosocomial pneumonia caused by gram-negative pathogens, according to results of a randomized phase 3 trial called APEKS-NP.

Using high-risk antibiotics is an independent predictor of hospital-associated Clostridioides difficile infections, or HA CDIs, according to a study published in Infection Control & Hospital Epidemiology.